Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, Klotz L, Arolt V, Wiendl H, Meuth SG, Alferink J.
Gross CC, et al. Among authors: arolt v.
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 12;3(6):e289. doi: 10.1212/NXI.0000000000000289. eCollection 2016 Dec.
Neurol Neuroimmunol Neuroinflamm. 2016.
PMID: 27766281
Free PMC article.